Kite Pharma's P2P Acquisition

Kite Pharma raised a round of funding on October 03, 2017. Investors include Gilead Sciences.

Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's abilit…

Articles about Kite Pharma's P2P Acquisition: